Cabaletta Bio, Inc. (CABA)
- Sector
- Biotechnology
- Last price
- $1.02
- As of
Kresmion compiles this page from CABA's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
Cabaletta Bio, Inc. (CABA): 1 institutional manager tracked by Kresmion reported non-option positions in their 2026Q3 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-11-09.
See the full CABA dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for CABA on one page. Preview it with sample data, then open it live with a free account.
Preview the CABA dossierActive events for CABA
- high13F: large reduction
RENAISSANCE TECHNOLOGIES LLC cut 82% of CABA (2026Q3)
- mediumEarnings above estimates
Q3-2026: Beat consensus by 13.3%, EPS $-0.28 vs $-0.323 estimate
- high13F: large increase
CITADEL ADVISORS LLC added +1482% to CABA (2026Q2)
- high13F: large increase
CITADEL ADVISORS LLC added +121% to CABA (2026Q2)
- high13F: large reduction
MILLENNIUM MANAGEMENT LLC cut 65% of CABA (2026Q2)
FREE, NO ACCOUNT
Every event on CABA, as it fires
You are seeing 5 of 15 events recorded on CABA since 2026-06-10.
The five above landed across 3 days. The other 10 were recorded on 4 other days. 8 of the 15 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
CABA positions held by the managers we follow (2026Q3)
What the managers we follow bought and sold in Q2 2026
| Manager / security | Market value | % of reported value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC FundCUSIP 12674W109 · 2026Q3 | $524K | 0.00% |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. The share of reported value is each position's value over the sum of the values that manager reported for the quarter; option lines are not in that sum, as on each fund page. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, CABA
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
More data on CABA
Related tickers
Cite this data
Kresmion counts the managers it follows that reported a non-option position in CABA on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on CABA in the last 180 days.
Upstream: SEC EDGAR filings for CABA
Kresmion, "Cabaletta Bio, Inc. (CABA) institutional holdings and SEC filings", data as of 2026-11-16, https://kresmion.com/research/CABA. Upstream data: SEC EDGAR filings for CABA.
Link to this data (HTML):
<a href="https://kresmion.com/research/CABA">Cabaletta Bio, Inc. (CABA) institutional holdings and SEC filings (Kresmion)</a>
Writing about this? Press contact and ready-to-quote figures
Follow CABA on a live board
Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to CABA for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.